New hope for severe autism: testing medication and ECT for debilitating catatonia
NCT ID NCT07498387
Summary
This study is testing two treatments to help control severe catatonia in teenagers with profound autism. Catatonia can cause extreme withdrawal, agitation, and loss of function. Researchers will first try a calming medication (benzodiazepine) and, if that doesn't work well enough, they will try electroconvulsive therapy (ECT) to see if either safely reduces symptoms and improves behavior over three months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Child and Adolescent Psychiatry Clinics, Psychiatry and Neurology Center, Tanta University
Tanta, El-Gharbia Governorate, 31527, Egypt
Conditions
Explore the condition pages connected to this study.